Dr Sulaiman Al Habib Medical Services Group (SAU:4013) EBIT: ﷼2,833 Mil (TTM As of Mar. 2026)


SAU:4013 Dr Sulaiman Al Habib Medical Services Group SAU:4013
92 GF Score
Price ﷼213.80
GF Value ﷼396.06
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dr Sulaiman Al Habib Medical Services Group EBIT?

Dr Sulaiman Al Habib Medical Services Group SAU:4013 -0.09% 92 EBIT is ﷼2,833 Mil as of Mar. 2026. GuruFocus rates SAU:4013 with a GF Score™ of 92/100 and a GF Value™ of ﷼396.06 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Dr Sulaiman Al Habib Medical Services Group's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ﷼644 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼2,833 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Dr Sulaiman Al Habib Medical Services Group's annualized ROC % for the quarter that ended in Mar. 2026 was 10.86%. Dr Sulaiman Al Habib Medical Services Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.76%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Dr Sulaiman Al Habib Medical Services Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.44%.


Dr Sulaiman Al Habib Medical Services Group  (SAU:4013) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Dr Sulaiman Al Habib Medical Services Group's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2350.98 * ( 1 - 4.85% )/( (20452.672 + 20737.402)/ 2 )
=2236.95747/20595.037
=10.86 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=23204.946 - 2043.658 - ( 2281.635 - max(0, 4718.655 - 5427.271+2281.635))
=20452.672

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=23766.27 - 2336.773 - ( 2415.363 - max(0, 4955.183 - 5647.278+2415.363))
=20737.402

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Dr Sulaiman Al Habib Medical Services Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2574.632/( ( (17302.419 + max(-1433.122, 0)) + (17573.462 + max(-1555.845, 0)) )/ 2 )
=2574.632/( ( 17302.419 + 17573.462 )/ 2 )
=2574.632/17437.9405
=14.76 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1622.407 + 1028.292 + 438.453) - (2043.658 + 0 + 2478.616)
=-1433.122

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1629.352 + 1154.034 + 448.529) - (2336.773 + 0 + 2450.987)
=-1555.845

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Dr Sulaiman Al Habib Medical Services Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2833.37/82454.482
=3.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Sulaiman Al Habib Medical Services Group EBIT Related Terms


Dr Sulaiman Al Habib Medical Services Group EBIT Historical Data

* Premium members only.

The historical data trend for Dr Sulaiman Al Habib Medical Services Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Sulaiman Al Habib Medical Services Group EBIT Chart

Dr Sulaiman Al Habib Medical Services Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 1,539.24 1,846.01 2,240.09 2,575.62 2,858.07

Dr Sulaiman Al Habib Medical Services Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 668.36 698.92 720.95 769.84 643.66

SAU:4013 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Dr Sulaiman Al Habib Medical Services Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Sulaiman Al Habib Medical Services Group EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dr Sulaiman Al Habib Medical Services Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dr Sulaiman Al Habib Medical Services Group's EV-to-EBIT falls into.


SAU:4013
92GF Score
Dr Sulaiman Al Habib Medical Services Group SAU:4013
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Sulaiman Al Habib Medical Services Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼2,833 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ﷼2,833 Mil mean?
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a EBIT of ﷼2,833 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Dr Sulaiman Al Habib Medical Services Group.
Is Dr Sulaiman Al Habib Medical Services Group's EBIT too high?
Dr Sulaiman Al Habib Medical Services Group's current EBIT is ﷼2,833 Mil. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's EBIT compare to HCA and THC?
Dr Sulaiman Al Habib Medical Services Group's EBIT of ﷼2,833 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Dr Sulaiman Al Habib Medical Services Group. Dr Sulaiman Al Habib Medical Services Group's current EBIT is ﷼2,833 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼396.06, compared to a current price of ﷼213.80 — trading 46% below its estimated fair value. The current EBIT is ﷼2,833 Mil. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current EBIT is ﷼2,833 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued. The current stock price of ﷼213.80 is trading 46% below its estimated GF Value™ of ﷼396.06. GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.

Key valuation signals for SAU:4013:

  • EBIT: ﷼2,833 Mil
  • GF Value™: ﷼396.06 vs. price of ﷼213.80 (46% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr Sulaiman Al Habib Medical Services Group Business Description

Address P.O. Box 301578, Al Olaya District, Riyadh, SAU, 11372
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
92GF Score

Get the complete analysis for SAU:4013

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼213.80
Price
﷼396.06
GF Value